🔍

STARHEALTH - Star Health Insu

📊 NSE: STARHEALTH 🏢 Finance & Investments 📅 Last Updated: 12/14/2025 13:43

📢 Recent Corporate Announcements

Star Health to Meet Amansa Capital on March 18, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 13 Mar 2026, 01:15 PM

Star Health and Allied Insurance Company Limited has scheduled an institutional investor meeting with Amansa Capital on March 18, 2026. The meeting is slated to take place in Chennai from 3:30 PM to 4:15 PM IST. This is a routine disclosure under SEBI Listing Regulations to maintain transparency with market participants. Investors can access the company's current presentation via the provided cloudfront link to understand the latest business updates.

Meeting with Amansa Capital scheduled for March 18, 2026, in Chennai.
Interaction window is 45 minutes, specifically from 3:30 PM to 4:15 PM IST.
Disclosure made under Regulation 30 of SEBI (LODR) Regulations, 2015.
Company has provided a direct link to the ECPQ 3 FY 26 presentation for investor reference.

💡 No immediate action is required as this is a standard investor relations event. Monitor for any post-meeting updates or changes in institutional holding patterns.

Star Health to Meet Massachusetts Institute of Technology on March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 06 Mar 2026, 05:09 PM

Star Health and Allied Insurance Company Limited has scheduled a meeting with the Massachusetts Institute of Technology (MIT) on March 11, 2026. The meeting is slated to take place in Chennai between 2:30 PM and 3:30 PM IST. This disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also shared a link to its latest investor presentation for public access.

One-on-one meeting scheduled with Massachusetts Institute of Technology (MIT) on March 11, 2026
The meeting is scheduled for a duration of one hour from 2:30 PM to 3:30 PM IST
The interaction will be held in Chennai as per the regulatory filing dated March 06, 2026
Company has provided a specific link to the ECPQ 3 FY 26 presentation for investor review

💡 This is a routine regulatory disclosure of an investor meeting. No immediate action is required, but investors may review the linked presentation to understand the company's current strategic focus.

Star Health to Meet Sumitomo Mitsui DS Asset Management on March 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 06 Mar 2026, 01:10 PM

Star Health and Allied Insurance Company Limited has scheduled a meeting with Sumitomo Mitsui DS Asset Management on Wednesday, March 11, 2026. The meeting is set to take place in Chennai between 12:30 PM and 1:30 PM IST. This interaction is part of the company's routine engagement with institutional investors under SEBI regulations. The company has also provided a link to its latest investor presentation for the third quarter of FY26.

Meeting scheduled with Sumitomo Mitsui DS Asset Management on March 11, 2026
One-hour interaction window from 12:30 PM to 1:30 PM IST
Meeting location designated as Chennai, subject to exigency changes
Investor presentation link for FY26 provided for public access

💡 Investors should monitor for any post-meeting disclosures or updates to the investor presentation that may provide insights into the company's growth trajectory. No immediate action is required as this is a standard institutional interaction.

Star Health to Meet 40+ Institutional Investors at IIFL Conference on February 25

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Feb 2026, 12:02 PM

Star Health and Allied Insurance Company Limited has scheduled a series of group meetings with over 40 institutional investors and analysts on February 25, 2026. The meetings will be held in Mumbai as part of the IIFL Conference across three distinct time slots. Notable participants include major global and domestic funds such as ABRDN, HDFC Pension Fund, TATA Mutual Fund, and PPFAS Asset Management. The company has provided a link to the specific presentation that will be discussed during these sessions.

Group meetings scheduled with over 40 institutional investors on February 25, 2026.
Participation from major entities including ABRDN, Ashmore UK, HDFC Pension Fund, and TATA Mutual Fund.
Meetings are organized into three time slots between 01:00 P.M. and 03:55 P.M. IST.
The event is part of the IIFL Conference being held in Mumbai.
A dedicated investor presentation link has been disclosed for public transparency.

💡 This is a routine regulatory disclosure. Investors should review the linked presentation for any updates on the company's growth strategy and operational performance.

Star Health to Meet ICICI Pru Life and Steinberg Asset Management on Feb 25

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Feb 2026, 11:57 AM

Star Health and Allied Insurance Company has scheduled meetings with institutional investors on February 25, 2026, as part of the IIFL Conference in Mumbai. The company will hold separate sessions with ICICI Prudential Life Insurance and Steinberg Asset Management between 10:00 AM and 11:55 AM. These interactions are routine investor relations activities aimed at discussing the company's performance and strategy. The company has also provided a link to its Q3 FY26 investor presentation for public review.

Meetings scheduled for February 25, 2026, during the IIFL Conference in Mumbai
Interaction with ICICI Prudential Life Insurance Co Ltd from 10:00 AM to 10:55 AM
Interaction with Steinberg Asset Management from 11:00 AM to 11:55 AM
Company has shared its Q3 FY26 investor presentation link for transparency
Disclosure made in compliance with Regulation 30 of SEBI LODR Regulations

💡 This is a routine disclosure; investors should review the linked Q3 FY26 presentation to understand the company's latest financial trajectory. No immediate action is required unless significant management commentary follows the conference.

Star Health Schedules Institutional Investor Meetings at Kotak Conference on Feb 24

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 18 Feb 2026, 03:32 PM

Star Health and Allied Insurance Company Limited has announced a series of meetings with institutional investors scheduled for February 24, 2026, in Mumbai. The company will interact with six major global and domestic funds, including Axis Asset Management, Schroder Investment Management, and Polar Capital, as part of the Kotak Conference. These interactions are part of the company's regular investor outreach program to discuss business strategy and performance. Investors can access the presentation via the provided link to gain insights into the company's current positioning.

Meetings scheduled with 6 major institutional investors on February 24, 2026
Participating firms include Janchor Partners, Polar Capital, Amansa, Axis AMC, Schroder, and Matthews
The event is part of the Kotak Conference held in Mumbai
Company has shared a specific presentation link for the meetings to ensure transparency

💡 Review the investor presentation for updates on market share and loss ratios. This is a routine engagement and does not necessitate immediate portfolio changes.

Star Health to Meet Major Institutional Investors at Kotak Conference on Feb 24

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 18 Feb 2026, 03:19 PM

Star Health and Allied Insurance Company has scheduled a series of meetings with prominent institutional investors on February 24, 2026, in Mumbai. The meetings are organized as part of the Kotak Conference and include high-profile firms such as Axis Asset Management, Polar Capital, and Schroder Investment Management. These interactions are standard practice for listed companies to discuss their business outlook and performance with the analyst community. The company has proactively shared the investor presentation link to maintain transparency with all stakeholders.

Meetings scheduled with 6 major institutional investors on February 24, 2026.
Key participants include Axis Asset Management, Polar Capital, and Schroder Investment Management.
The engagement is part of the Kotak Conference held in Mumbai.
Company has provided a public link to its latest investor presentation for FY26.

💡 Investors should review the company's latest presentation to stay updated on management's growth strategy. No immediate action is required as this is a routine disclosure of investor relations activity.

Star Health Appoints Himanshu Walia and Amitabh Jain as Whole-time Directors for 5 Years

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 11 Feb 2026, 06:14 PM

Star Health has received IRDAI approval to appoint Mr. Himanshu Walia and Mr. Amitabh Jain as Whole-time Directors and Key Managerial Personnel for a five-year term starting February 11, 2026. Mr. Walia, the current Chief Marketing Officer, has been with the company since 2007 and brings over 22 years of insurance experience. Mr. Jain, the current Chief Operating Officer and a former founding member of ICICI Lombard, has over 25 years of experience in financial services. These appointments strengthen the leadership team by elevating experienced internal executives to the board level.

Appointment of two Whole-time Directors for a fixed term of 5 years effective February 11, 2026
Mr. Himanshu Walia (CMO) brings 22+ years of experience and has been with Star Health since 2007
Mr. Amitabh Jain (COO) has 25+ years of experience and was a founding member of ICICI Lombard
Appointments have received formal regulatory approval from IRDAI

💡 Investors should view this as a positive move for leadership continuity and operational stability. Monitor the company's execution on digital transformation and market share growth under this strengthened leadership team.

Star Health to Meet Over 40 Institutional Investors on February 11, 2026

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 06 Feb 2026, 06:46 PM

Star Health and Allied Insurance Company has scheduled a series of group meetings with over 40 major institutional investors and analysts on February 11, 2026. The meetings are part of the Nuvama Conference in Mumbai and will be conducted across four distinct time slots throughout the day. High-profile participants include Goldman Sachs Asset Management, HDFC AMC, SBI Funds Management, and Fidelity Management and Research. This large-scale interaction indicates continued strong institutional interest in the company's performance and outlook.

Series of group meetings scheduled for February 11, 2026, at the Nuvama Conference in Mumbai.
Participation from over 40 prominent domestic and international investment firms.
Four specific time slots allocated between 12:00 PM and 5:50 PM for different investor groups.
Key attendees include top-tier names like ICICI Prudential Life, Goldman Sachs, and SBI Funds Management.
Company has provided a public link to the presentation to be used during these meetings.

💡 Investors should monitor for any management commentary or updates on growth guidance and loss ratios that may emerge following these meetings. The high volume of institutional participation suggests the stock remains a significant focus for large-scale fund managers.

Star Health to Meet 40+ Institutional Investors at Nuvama Conference on Feb 11

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 06 Feb 2026, 06:40 PM

Star Health and Allied Insurance has scheduled a series of group meetings with over 40 institutional investors on February 11, 2026, in Mumbai. The meetings, conducted as part of the Nuvama Conference, will feature major participants such as HDFC AMC, ICICI Prudential Life, and Goldman Sachs. These sessions are organized into four distinct time slots throughout the day to facilitate broad institutional engagement. The company has proactively shared its investor presentation link to ensure transparency and regulatory compliance.

Meetings are scheduled for February 11, 2026, across four sessions between 12:00 PM and 5:50 PM.
Over 40 unique institutional investors and fund houses, including SBI Funds Management and Fidelity, are confirmed to participate.
The interaction is part of the organized Nuvama Conference held in Mumbai.
The company has provided a public link to its investor presentation for all stakeholders.

💡 Investors should monitor for any post-conference analyst reports or updates to the investor presentation that may provide insights into the company's growth trajectory. This is a routine disclosure and does not require immediate trading action.

Star Health Schedules Meeting with East Bridge Capital Management for February 10, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 05 Feb 2026, 06:34 PM

Star Health and Allied Insurance Company Limited has announced a scheduled meeting with East Bridge Capital Management on February 10, 2026. The meeting is set to take place in Chennai from 11:00 AM to 12:00 Noon. This disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also provided a link to its latest investor presentation for public access.

Meeting with East Bridge Capital Management scheduled for February 10, 2026, in Chennai.
Interaction window is set for one hour between 11:00 AM and 12:00 Noon.
Company has shared a specific cloudfront link for the latest investor presentation.
The meeting is subject to changes due to exigencies on the part of the analysts or the company.

💡 No immediate action is required as this is a routine investor engagement. Investors should review the provided presentation link to stay updated on the company's growth strategy and operational metrics.

Star Health to Meet ICICI Prudential AMC on February 4, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 03 Feb 2026, 06:53 PM

Star Health and Allied Insurance Company Limited has scheduled an institutional investor meeting with ICICI Prudential AMC on February 4, 2026, at 01:30 PM IST in Mumbai. The company noted that the meeting was organized at short notice due to business exigencies on the part of the investor. A specific presentation for the third quarter of FY26 has been made available via a public link for transparency. This interaction is part of the company's regular engagement with major institutional shareholders.

Meeting scheduled with ICICI Prudential AMC on February 4, 2026, at 1:30 PM IST.
The interaction will be held in-person in Mumbai.
Company issued a shorter notice for the meeting, citing business exigencies from the investor's side.
A dedicated presentation link (ECPQ_3_FY_26) has been disclosed for public access.
Star Health expressed regret for the short notice and committed to timely future intimations.

💡 Investors should review the linked presentation to understand the latest business updates and monitor for any post-meeting disclosures or transcripts. No immediate portfolio changes are recommended based on this routine institutional interaction.

Star Health Q3 FY26 PAT Jumps to ₹449 Cr; Combined Ratio Improves to 98.9%

🟢 POSITIVE ⭐ 9/10

EARNINGS 📅 03 Feb 2026, 06:33 PM

Star Health reported a robust Q3 FY2026 with Gross Written Premium (GWP) increasing 23% YoY to ₹5,047 crore, supported by a 45% surge in fresh business. Profit After Tax (PAT) under IND AS rose significantly to ₹449 crore from ₹87 crore in the previous year, driven by a 320 bps improvement in the combined ratio to 98.9%. The company maintained its market leadership with a 31.3% retail health market share and improved its 9M PAT by 87% YoY to ₹966 crore. Management highlighted a strategic shift towards high-margin retail business, which now constitutes 95% of the total portfolio.

Q3 GWP grew 23% YoY to ₹5,047 crore, with fresh business growth at 45% and renewal growth at 17%.
Combined ratio improved by 320 bps YoY to 98.9% in Q3 FY26, leading to an underwriting profit of ₹46 crore.
9M FY26 PAT increased 87% YoY to ₹966 crore, supported by an investment yield of 9.6%.
Retail loss ratio decreased to 68.4% in Q3 FY26, down 103 bps from the previous year.
Digital D2C channel grew 35% YoY in 9M FY26, contributing 20% of all fresh business premiums.

💡 Investors should note the significant operational turnaround as the company achieved underwriting profitability and a sub-100% combined ratio. The strong growth in the high-margin retail and digital segments, coupled with disciplined claims management, makes the stock a strong play on the expanding Indian health insurance sector.

Star Health Seeks Reclassification of Two Promoter Group Entities to Public Category

🟡 NEUTRAL ⭐ 3/10

REGULATORY 📅 30 Jan 2026, 05:54 PM

Star Health and Allied Insurance has formally applied to BSE and NSE for the reclassification of Ebono Private Limited and GS E-commerce Private Limited from the 'Promoter Group' to the 'Public' category. This application follows the Board's approval on January 28, 2026, and is in compliance with SEBI LODR Regulations. Significantly, both entities currently hold zero shares in the company, making this a procedural administrative change. The move does not impact the existing shareholding structure or management control of the insurer.

Application submitted to stock exchanges on January 30, 2026, for promoter reclassification.
Entities involved are Ebono Private Limited and GS E-commerce Private Limited.
Both entities currently hold 0 (Nil) shares in the company.
The reclassification follows the Board of Directors' approval granted on January 28, 2026.
The process is being conducted under Regulation 31A(8)(c) of SEBI LODR Regulations.

💡 This is a routine regulatory update with no impact on the company's fundamentals or shareholding float. No action is required from investors.

Star Health Releases Q3 & 9M FY2026 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 29 Jan 2026, 01:25 PM

Star Health and Allied Insurance Company Limited has released the audio recording of its Q3 and 9M FY2026 earnings conference call held on January 29, 2026. This disclosure follows the company's previous notification on January 14, 2026, regarding the scheduled call. The recording provides investors and analysts with direct access to management's discussion on financial performance and strategic outlook. Such filings are a routine part of regulatory compliance to ensure transparency for all shareholders.

Official audio recording link for Q3 & 9M FY2026 earnings call is now live.
The call was conducted on January 29, 2026, following the quarterly results.
The disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations.
Investors can access the recording via the provided Cloudfront link for detailed management commentary.

💡 Investors should listen to the recording to understand management's perspective on loss ratios and premium growth. No immediate action is required as this is a procedural update.

View All STARHEALTH Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Retail Health GWP grew 17% YoY to INR 8,332 Cr in H1 FY2026, driven by 24% growth in fresh retail premiums. In FY2025, the Agency channel contributed 82% of GWP with 16% YoY fresh business growth, while Digital grew 71% in fresh business, Banca grew 13%, and MSME grew 21%.

Geographic Revenue Split

The company operates across 25 states and 5 Union Territories, covering 724 out of 19,101 PIN codes. It maintains a branch network 3x larger than its nearest private competitor with 913 branches.

Profitability Margins

Profit After Tax (PAT) for FY2025 was INR 787 Cr, down from INR 1,103 Cr in FY2024. Return on Equity (ROE) stood at 9.5%. The combined ratio under IND AS was 101.1% in FY2025 compared to 97.3% in FY2024.

EBITDA Margin

Underwriting profitability was impacted by a claims ratio of 70.7% in FY2025 (up from 70.3% in FY2024). Expense of Management (EOM) was 30.7% in FY2024, providing operational flexibility below the 35% regulatory cap.

Capital Expenditure

Not explicitly disclosed in INR Cr, but the company added 74,000 new agents in FY2025 and expanded its home healthcare services to 156 cities.

Credit Rating & Borrowing

Maintains comfortable solvency at 2.21x as of March 2025, well above the 1.5x regulatory requirement. Solvency is supported by INR 470 Cr of subordinate debt.

⚙️ Operational Drivers

Raw Materials

Claims Outgo (70.7% of GWP), Commission/Brokerage, and Operating Expenses (30.4% Expense Ratio).

Import Sources

Not applicable for insurance services; sourcing refers to domestic healthcare provider networks.

Key Suppliers

Network of 14,203 hospitals as of March 31, 2023, with 67% of claims paid via Agreed Network Hospitals (ANH).

Capacity Expansion

Current agent count is 7.75 lakhs, with a planned expansion to 1 million agents over the next three years to deepen penetration in non-metro cities.

Raw Material Costs

Claims ratio increased to 70.7% in FY2025 due to higher frequency and severity of hospitalizations. Proprietary AIML fraud detection delivered 35% savings growth in claims outgo.

Manufacturing Efficiency

96% of cashless claims processed within 3 hours; claim rejection rate reduced from 13% to 10% in FY2025.

Logistics & Distribution

Agency channel is the cornerstone, contributing 82% of GWP. Digital segment accounts for 8% of total business.

📈 Strategic Growth

Expected Growth Rate

16%

Growth Strategy

Recalibration of group business (reducing GWP contribution from 9% to 7%), exiting unprofitable employer-employee portfolios, and repricing 65% of the retail book. Expansion of the agent network to 1 million and focus on high sum insured policies.

Products & Services

Retail health insurance policies, MSME/SME group insurance, and specialized products like the 'Superstar' policy and India's first Braille policy for the visually impaired.

Brand Portfolio

Star Health and Allied Insurance, Superstar Policy.

New Products/Services

Superstar policy (generated INR 580 Cr GWP), Braille policy, and tailored products for Gen Z and senior citizens under the FY2026 'Year of the Customer' initiative.

Market Expansion

Deepening penetration in non-metro cities and emerging towns via the 1-million agent expansion plan and 1,000+ Sales Manager Stations.

Market Share & Ranking

Largest standalone health insurer (SAHI) in India with 44% SAHI market share and 32-33% retail health market share.

Strategic Alliances

Banca channel partnerships with over 20,000 bank branches; 7% contribution to total business.

🌍 External Factors

Industry Trends

Health insurance industry (SAHI) grew at 25% CAGR (2019-2024). Future direction involves digital-first adoption (71% fresh digital business growth) and regulatory reporting shifts to annual premiums.

Competitive Landscape

Faces competition from general insurers and other SAHI players; Star maintains leadership despite a slight market share moderation from 33% to 32%.

Competitive Moat

Dominant retail market share (33%), massive distribution network (7.75 lakh agents), and 3x branch count vs competitors create high barriers to entry and network effects.

Macro Economic Sensitivity

Healthcare inflation and rising awareness of indemnity-based products drive demand; GDP growth supports middle-class insurance adoption.

Consumer Behavior

Shift toward higher sum assured and digital-to-consumer platforms (Star's online channel contributes 72% of its digital business).

Geopolitical Risks

Minimal direct impact due to domestic focus, though global economic developments can influence investment yields (7.7% in FY2025).

⚖️ Regulatory & Governance

Industry Regulations

IRDAI mandates a 1.5x solvency ratio (Star is at 2.21x). New IRDAI reporting guidelines for long-tail policies (10% of Star's premium) impacted reported growth metrics.

Environmental Compliance

Rated India's most sustainable insurer by S&P Global with an ESG score of 53.

Taxation Policy Impact

Effective tax rate implied by PBT of INR 1,054 Cr and PAT of INR 787 Cr (approx 25.3%).

Legal Contingencies

Not disclosed in available documents; internal controls are reviewed quarterly by the Audit Committee.

⚠️ Risk Analysis

Key Uncertainties

Single line of business risk (health only) exposes the company to event risks like pandemics or high claims inflation (claims ratio rose to 70.7%).

Geographic Concentration Risk

Covers 25 states; however, the company is consciously curtailing growth in 'riskier geographies' to maintain underwriting profitability.

Third Party Dependencies

Dependency on 20,000 partner bank branches for the Banca channel (7% of business) and 14,203 network hospitals.

Technology Obsolescence Risk

Mitigated by digital-first strategy, 1 Cr app downloads, and proprietary AIML platforms for fraud detection.

Credit & Counterparty Risk

Receivables quality is generally high in retail insurance due to upfront premium payments; investment portfolio of INR 17,889 Cr is the primary counterparty risk area.